| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/16/2008 | EP1911461A2 HLA class I and II binding peptides and their uses |
| 04/16/2008 | EP1910844A2 Cross-beta structure binding compounds |
| 04/16/2008 | EP1910837A2 Methods and compositions for diagnosis and treatment of influenza |
| 04/16/2008 | EP1910829A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 04/16/2008 | EP1910828A2 Phosphospecific chemokine receptor antibodies |
| 04/16/2008 | EP1910573A2 Methods for reducing viral load in hiv-1-infected patients |
| 04/16/2008 | EP1910420A2 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 04/16/2008 | EP1910419A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/16/2008 | EP1910410A2 Tuberculosis antigen detection assays and vaccines |
| 04/16/2008 | EP1910409A2 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 04/16/2008 | EP1910408A2 Bifunctional protein anchors |
| 04/16/2008 | EP1909836A2 Methods for treating and detecting beta-cell disease |
| 04/16/2008 | EP1909834A2 Use of hmgb1 antagonists for the treatment of inflammatory skin conditions |
| 04/16/2008 | EP1909832A1 Antibody-immune cell ligand fusion protein for cancer therapy |
| 04/16/2008 | EP1909831A2 Self-buffering protein formulations |
| 04/16/2008 | EP1909830A2 Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 04/16/2008 | EP1909829A2 Recombinant flu vaccines |
| 04/16/2008 | EP1909828A2 Methods and compositions relating to a vaccine against prostate cancer |
| 04/16/2008 | EP1909827A2 The modulation of immunity and ceacam1 activity |
| 04/16/2008 | EP1909819A2 Receptor antagonists for treatment of metastatic bone cancer |
| 04/16/2008 | EP1703914B1 Apicomplex vaccine strains of a family of sarcocystidae |
| 04/16/2008 | EP1539820B1 Ostertagia vaccine |
| 04/16/2008 | EP1467771B1 Mycobacterial vaccine |
| 04/16/2008 | EP1343823B1 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 04/16/2008 | EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/16/2008 | EP1222283B1 Dna immunization against chlamydia infection |
| 04/16/2008 | EP1169353B1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/16/2008 | EP1109574B1 Vaccine against sexually transmitted diseases |
| 04/16/2008 | EP0984023B9 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/16/2008 | EP0931093B1 Helicobacter pylori live vaccine |
| 04/16/2008 | EP0885244B2 Peptide immunogens for vaccination against and treatment of allergy |
| 04/16/2008 | CN101163718A Reagents that bind ccx-ckr2 |
| 04/16/2008 | CN101163714A Influenza nucleic acids, polypeptides, and uses thereof |
| 04/16/2008 | CN101163508A Integration of meningococcal conjugate vaccination |
| 04/16/2008 | CN101163503A Extending time to disease progression or survival in cancer patients using her dimerization inhibitor |
| 04/16/2008 | CN101163502A Antibodies to tgf-beta |
| 04/16/2008 | CN101163501A Bispecific binding agents for modulating biological activity |
| 04/16/2008 | CN101163500A Composition for adjuvant containing poly-gamma-glutamic acid |
| 04/16/2008 | CN101163499A Surface-located streptococcus pneumoniae polypeptides |
| 04/16/2008 | CN101163498A Methods and reagents for diagnosing hantavirus infection |
| 04/16/2008 | CN101163468A Novel combinational use of sulfonamide compound |
| 04/16/2008 | CN101161676A Saltant APOBEC3G molecule inhibiting HIV reproduction and uses thereof |
| 04/16/2008 | CN101161287A A anastomosing protein contraception vaccine carrying human molecule adjuvant and its preparing method |
| 04/16/2008 | CN101161286A Varicella attenuation live vaccine |
| 04/16/2008 | CN101161285A Influenza virus cracking vaccine |
| 04/16/2008 | CN101161283A New use of CMTM1-v17 and its antagon |
| 04/16/2008 | CN101161232A Method of producing intravenous injection human hepatitis b immune globulin |
| 04/16/2008 | CN100381467C UreG protein, and its preparing method and sue |
| 04/16/2008 | CN100381464C Multiple variants of meningococcal protein NMB1870 |
| 04/16/2008 | CN100381463C Immunogen for producing vaccine or medicine to treat hepatitis B, its preparation process and use |
| 04/16/2008 | CN100381460C HER-2 analogue antigen epitope and peptide containing said epitope |
| 04/16/2008 | CN100381173C Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 04/16/2008 | CN100381172C Treating prostate cancer with anti-ErbB2 antibodies |
| 04/16/2008 | CN100381171C Composite hepatitis B virus surface antigen granule containing S1, S2 and S proantigen determinants |
| 04/16/2008 | CN100381170C Foot and mouth disease bivalent polypeptide vaccine and its preparation method and use |
| 04/16/2008 | CA2567394A1 Glycoprotein vi antibodies and methods of use thereof |
| 04/15/2008 | US7358355 Antibodies against human parathyroid hormone related protein |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358353 Expose cells to gene and nucleotide sequence that encodes T or B cell epitope; generates antibodies that bind specifically; immunogenic |
| 04/15/2008 | US7358352 Tumor necrosis factor; isolating protein from cell culture; use in drug discovery screens compounds that block synthesis |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358340 PRO19563 antibodies |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358234 Induction of a protective immune response through microprojectiles coated with a DNA sequence encoding an immunogenic protein |
| 04/15/2008 | US7358222 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
| 04/15/2008 | US7358087 Adjuvant for enhancing immune response to preferential immunogen |
| 04/15/2008 | US7358061 Methods of diagnosing thyroid carcinoma |
| 04/15/2008 | US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/15/2008 | US7358053 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 04/15/2008 | US7358045 Using engrailed-2 (En-2) gene expression as a diagnostic and prognostic indicator of mammary gland cell proliferative disorders; antisense agents |
| 04/15/2008 | US7358042 Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 04/15/2008 | US7357936 immunostimulant (3-de-O-acylated monophosphoryl lipid A) adsorbed onto metallic salt (aluminium hydroxide or aluminium phosphate); second salt with antigen which elicits immune response to polypeptide or pathogen; Hepatitis, human papilloma virus |
| 04/15/2008 | US7357935 Genetic engineered mutant against Escherichia; veterinary medicine |
| 04/15/2008 | US7357934 Intracranial botulinum toxin therapy for focal epilepsy |
| 04/15/2008 | US7357932 Surface protein of Neisseria bacteria |
| 04/15/2008 | US7357931 Gene expression inhibition; drug screening; peroxisome proliferator-activated receptor agonists such as fenofibrate |
| 04/15/2008 | US7357930 Methods and formulations for targeting infectious agents bearing host cell proteins |
| 04/15/2008 | US7357929 Placental growth factor as a target for the treatment of osteoporosis |
| 04/15/2008 | US7357928 Proteins for treatment of cancer by administering antinucleolin |
| 04/15/2008 | US7357927 Death domain containing receptors |
| 04/15/2008 | US7357926 Antibodies against PRO1879 and the use thereof |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | US7357914 Use of metal chelates in human or animal feeding |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/15/2008 | CA2263201C Cross-protective equine herpesvirus preparations and method of making and using the same |
| 04/15/2008 | CA2169764C Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 04/15/2008 | CA2082155C Swine pneumonia vaccine and method of preparation |
| 04/12/2008 | CA2603199A1 Shigella ipad protein and its use as a vaccine against shigella infection |
| 04/12/2008 | CA2563214A1 Shigella ipad protein and its use as a potential vaccine against shigella infection |
| 04/10/2008 | WO2008043072A2 Cd80 antagonists for treating neoplastic disorders |
| 04/10/2008 | WO2008043018A1 Tumor immunity |
| 04/10/2008 | WO2008042941A2 Humanized anti-ephb4 antibodies and their use in treatment of oncology and vasculogenesis-related disease |
| 04/10/2008 | WO2008042814A2 Mart-1 t cell receptors |
| 04/10/2008 | WO2008042789A1 Norovirus vaccine formulations |
| 04/10/2008 | WO2008042611A2 Method of using il6 antagonists with mitoxantrone for prostate cancer |
| 04/10/2008 | WO2008042479A2 Methods and compositions related to bacterial flagellum and nanotube formation |
| 04/10/2008 | WO2008042469A2 Knockout mice for different genes and their use for gene characterizatio |
| 04/10/2008 | WO2008042436A2 Biomarkers and assays for the treatment of cancer |